Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 124

1.

The ErbB3-binding protein EBP1 modulates lapatinib sensitivity in prostate cancer cells.

Awasthi S, Ezelle H, Hassel BA, Hamburger AW.

Mol Cell Biochem. 2015 Jul;405(1-2):177-86. doi: 10.1007/s11010-015-2409-z. Epub 2015 Apr 17.

PMID:
25876877
2.

Regulation of ribosomal RNA synthesis in T cells: requirement for GTP and Ebp1.

Nguyen le XT, Lee Y, Urbani L, Utz PJ, Hamburger AW, Sunwoo JB, Mitchell BS.

Blood. 2015 Apr 16;125(16):2519-29. doi: 10.1182/blood-2014-12-616433. Epub 2015 Feb 17.

3.

Functional cyclic AMP response element in the breast cancer resistance protein (BCRP/ABCG2) promoter modulates epidermal growth factor receptor pathway- or androgen withdrawal-mediated BCRP/ABCG2 transcription in human cancer cells.

Xie Y, Nakanishi T, Natarajan K, Safren L, Hamburger AW, Hussain A, Ross DD.

Biochim Biophys Acta. 2015 Mar;1849(3):317-27. doi: 10.1016/j.bbagrm.2015.01.003. Epub 2015 Jan 21.

4.

Heregulin negatively regulates transcription of ErbB2/3 receptors via an AKT-mediated pathway.

Awasthi S, Hamburger AW.

J Cell Physiol. 2014 Nov;229(11):1831-41. doi: 10.1002/jcp.24637.

5.

Regulation of tamoxifen sensitivity by a PAK1-EBP1 signalling pathway in breast cancer.

Ghosh A, Awasthi S, Peterson JR, Hamburger AW.

Br J Cancer. 2013 Feb 19;108(3):557-63. doi: 10.1038/bjc.2013.11. Epub 2013 Jan 29.

6.

ErbB3-binding protein EBP1 decreases ErbB2 levels via a transcriptional mechanism.

Ghosh A, Awasthi S, Hamburger AW.

Oncol Rep. 2013 Mar;29(3):1161-6. doi: 10.3892/or.2012.2186. Epub 2012 Dec 14.

7.
8.

The ErbB3 binding protein EBP1 regulates ErbB2 protein levels and tamoxifen sensitivity in breast cancer cells.

Lu Y, Zhou H, Chen W, Zhang Y, Hamburger AW.

Breast Cancer Res Treat. 2011 Feb;126(1):27-36. doi: 10.1007/s10549-010-0873-4. Epub 2010 Apr 9.

9.

Post-transcriptional regulation of androgen receptor mRNA by an ErbB3 binding protein 1 in prostate cancer.

Zhou H, Mazan-Mamczarz K, Martindale JL, Barker A, Liu Z, Gorospe M, Leedman PJ, Gartenhaus RB, Hamburger AW, Zhang Y.

Nucleic Acids Res. 2010 Jun;38(11):3619-31. doi: 10.1093/nar/gkq084. Epub 2010 Feb 16.

10.

Side-population cells in luminal-type breast cancer have tumour-initiating cell properties, and are regulated by HER2 expression and signalling.

Nakanishi T, Chumsri S, Khakpour N, Brodie AH, Leyland-Jones B, Hamburger AW, Ross DD, Burger AM.

Br J Cancer. 2010 Mar 2;102(5):815-26. doi: 10.1038/sj.bjc.6605553. Epub 2010 Feb 9.

11.

Androgen deprivation and stem cell markers in prostate cancers.

Tang Y, Hamburger AW, Wang L, Khan MA, Hussain A.

Int J Clin Exp Pathol. 2009 Nov 10;3(2):128-38.

12.

ErbB3 binding protein 1 represses metastasis-promoting gene anterior gradient protein 2 in prostate cancer.

Zhang Y, Ali TZ, Zhou H, D'Souza DR, Lu Y, Jaffe J, Liu Z, Passaniti A, Hamburger AW.

Cancer Res. 2010 Jan 1;70(1):240-8. doi: 10.1158/0008-5472.CAN-09-2904.

13.

Alterations in cell growth and signaling in ErbB3 binding protein-1 (Ebp1) deficient mice.

Zhang Y, Lu Y, Zhou H, Lee M, Liu Z, Hassel BA, Hamburger AW.

BMC Cell Biol. 2008 Dec 18;9:69. doi: 10.1186/1471-2121-9-69.

14.

EBP1, an ErbB3-binding protein, is decreased in prostate cancer and implicated in hormone resistance.

Zhang Y, Linn D, Liu Z, Melamed J, Tavora F, Young CY, Burger AM, Hamburger AW.

Mol Cancer Ther. 2008 Oct;7(10):3176-86. doi: 10.1158/1535-7163.MCT-08-0526.

15.

The role of ErbB3 and its binding partners in breast cancer progression and resistance to hormone and tyrosine kinase directed therapies.

Hamburger AW.

J Mammary Gland Biol Neoplasia. 2008 Jun;13(2):225-33. doi: 10.1007/s10911-008-9077-5. Epub 2008 Apr 19. Review.

16.

Inhibition of heregulin mediated MCF-7 breast cancer cell growth by the ErbB3 binding protein EBP1.

Zhang Y, Akinmade D, Hamburger AW.

Cancer Lett. 2008 Jul 8;265(2):298-306. doi: 10.1016/j.canlet.2008.02.024. Epub 2008 Mar 19.

17.

Phosphorylation of the ErbB3 binding protein Ebp1 by p21-activated kinase 1 in breast cancer cells.

Akinmade D, Talukder AH, Zhang Y, Luo WM, Kumar R, Hamburger AW.

Br J Cancer. 2008 Mar 25;98(6):1132-40. doi: 10.1038/sj.bjc.6604261. Epub 2008 Feb 19.

18.

Cancer stem cells and individualized therapy.

Chumsri S, Phatak P, Edelman MJ, Khakpour N, Hamburger AW, Burger AM.

Cancer Genomics Proteomics. 2007 May-Jun;4(3):165-74. Review.

19.

Ebp1-mediated inhibition of cell growth requires serine 363 phosphorylation.

Akinmade D, Lee M, Zhang Y, Hamburger AW.

Int J Oncol. 2007 Oct;31(4):851-8.

PMID:
17786317
20.

Suppression of salivary adenoid cystic carcinoma growth and metastasis by ErbB3 binding protein Ebp1 gene transfer.

Yu Y, Chen W, Zhang Y, Hamburger AW, Pan H, Zhang Z.

Int J Cancer. 2007 May 1;120(9):1909-13.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk